The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis
Open accessAbstract
Epithelial-mesenchymal transition (EMT) is a reversible plethora of molecular events where epithelial cells gain the phenotype of mesenchymal cells to invade the surrounding tissues. EMT is a physiological event during embryogenesis (type I) but also happens during fibrosis (type II) and cancer metastasis (type III). It is a multifaceted phenomenon governed by the activation of genes associated with cell migration, extracellular matrix degradation, DNA repair, and angiogenesis. The cancer cells employ EMT to acquire the ability to migrate, resist therapeutic agents and escape immunity. One of the key biomarkers of EMT is vimentin, a type III intermediate filament that is normally expressed in mesenchymal cells but is upregulated during cancer metastasis. This review highlights the pivotal role of vimentin in the key events during EMT and explains its role as a downstream as well as an upstream regulator in this highly complex process. This review also highlights the areas that require further research in exploring the role of vimentin in EMT. As a cytoskeletal protein, vimentin filaments support mechanical integrity of the migratory machinery, generation of directional force, focal adhesion modulation and extracellular attachment. As a viscoelastic scaffold, it gives stress-bearing ability and flexible support to the cell and its organelles. However, during EMT it modulates genes for EMT inducers such as Snail, Slug, Twist and ZEB1/2, as well as the key epigenetic factors. In addition, it suppresses cellular differentiation and upregulates their pluripotent potential by inducing genes associated with self-renewability, thus increasing the stemness of cancer stem cells, facilitating the tumour spread and making them more resistant to treatments. Several missense and frameshift mutations reported in vimentin in human cancers may also contribute towards the metastatic spread. Therefore, we propose that vimentin should be a therapeutic target using molecular technologies that will curb cancer growth and spread with reduced mortality and morbidity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
Dang, C. V. (2012) · Cell · doi:10.1016/j.cell.2012.03.003 · Cited by 3,390
EMT Transition States during Tumor Progression and Metastasis
Pastushenko, I., & Blanpain, C. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.12.001 · Cited by 2,876
Apoptosis in cancer: from pathogenesis to treatment
Wong, R. S. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-87 · Cited by 2,836
Signaling mechanisms of the epithelial-mesenchymal transition
Gonzalez, D. M., & Medici, D. (2014) · Science Signaling · doi:10.1126/scisignal.2005189 · Cited by 1,721
Epithelial-Mesenchymal Transitions
Kang, Y., & Massagué, J. (2004) · Cell · doi:10.1016/j.cell.2004.07.011 · Cited by 1,525
Compensation mechanism in tumor cell migration
Wolf, K., Mazo, I., Leung, H., Engelke, K., von Andrian, U. H., Deryugina, E. I., Strongin, A. Y., Bröcker, E.-B., & Friedl, P. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200209006 · Cited by 1,391
Loh, C.-Y., Chai, J., Tang, T., Wong, W., Sethi, G., Shanmugam, M., Chong, P., & Looi, C. (2019) · Cells · doi:10.3390/cells8101118 · Cited by 1,315
The epigenetics of epithelial-mesenchymal plasticity in cancer
Tam, W. L., & Weinberg, R. A. (2013) · Nature Medicine · doi:10.1038/nm.3336 · Cited by 1,163
Anoikis molecular pathways and its role in cancer progression
Paoli, P., Giannoni, E., & Chiarugi, P. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.026 · Cited by 1,160
Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology
Semenza, G. L. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104720 · Cited by 1,159
Epithelial–mesenchymal plasticity in carcinoma metastasis
Tsai, J. H., & Yang, J. (2013) · Genes & Development · doi:10.1101/gad.225334.113 · Cited by 1,136
Liu, S., Cong, Y., Wang, D., Sun, Y., Deng, L., Liu, Y., Martin-Trevino, R., Shang, L., McDermott, S. P., Landis, M. D., et al. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.11.009 · Cited by 1,053
EMT, MET, Plasticity, and Tumor Metastasis
Bakir, B., Chiarella, A. M., Pitarresi, J. R., & Rustgi, A. K. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.07.003 · Cited by 1,010
Cancer stem cells—Origins and biomarkers: Perspectives for targeted personalized therapies
Walcher, L., Kistenmacher, A.-K., Suo, H., Kitte, R., Dluczek, S., Strauß, A., Blaudszun, A.-R., Yevsa, T., Fricke, S., & Kossatz-Boehlert, U. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01280 · Cited by 1,007 · cited 1×
“This switching is conducted by the complex interactions of various transcription factors, signalling pathways and microenvironmental factors [30].”
BackgroundMechanisms of 3D cell migration
Yamada, K. M., & Sixt, M. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0172-9 · Cited by 884
The Role of Snail in EMT and Tumorigenesis
Wang, Y., Shi, J., Chai, K., Ying, X., & Zhou, B. (2013) · Current Cancer Drug Targets · doi:10.2174/15680096113136660102 · Cited by 875
Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast
Scheel, C., Eaton, E. N., Li, S. H.-J., Chaffer, C. L., Reinhardt, F., Kah, K.-J., Bell, G., Guo, W., Rubin, J., Richardson, A. L., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.029 · Cited by 858
Vuoriluoto, K., Haugen, H., Kiviluoto, S., Mpindi, J.-P., Nevo, J., Gjerdrum, C., Tiron, C., Lorens, J. B., & Ivaska, J. (2011) · Oncogene · doi:10.1038/onc.2010.509 · Cited by 647
Yu, Z., Pestell, T. G., Lisanti, M. P., & Pestell, R. G. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.08.022 · Cited by 647
ZEB1: At the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance
Zhang, P., Sun, Y., & Ma, L. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1006048 · Cited by 611 · cited 1×
“They bind to the E-Box sequence in the promoter of E-cadherin and downregulate its expression to support cell migration [71].”
BackgroundAnido, J., Sáez-Borderías, A., Gonzàlez-Juncà, A., Rodón, L., Folch, G., Carmona, M. A., Prieto-Sánchez, R. M., Barba, I., Martínez-Sáez, E., Prudkin, L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.023 · Cited by 572
EMT and inflammation: inseparable actors of cancer progression
Suarez‐Carmona, M., Lesage, J., Cataldo, D., & Gilles, C. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12095 · Cited by 566
Liu, C.-Y., Lin, H.-H., Tang, M.-J., & Wang, Y.-K. (2015) · Oncotarget · doi:10.18632/oncotarget.3862 · Cited by 533
Zhu, C., Wei, Y., & Wei, X. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1090-3 · Cited by 488
The Epithelial-to-Mesenchymal Transition in Cancer
Roche, J. (2018) · Cancers · doi:10.3390/cancers10020052 · Cited by 435
Cancer Invasion: Patterns and Mechanisms
Krakhmal, N. V., Zavyalova, M. V., Denisov, E. V., Vtorushin, S. V., & Perelmuter, V. M. (2015) · Acta Naturae · doi:10.32607/20758251-2015-7-2-17-28 · Cited by 374
EMT and MET : necessary or permissive for metastasis?
Jolly, M. K., Ware, K. E., Gilja, S., Somarelli, J. A., & Levine, H. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12083 · Cited by 371
EMT Factors and Metabolic Pathways in Cancer
Georgakopoulos-Soares, I., Chartoumpekis, D. V., Kyriazopoulou, V., & Zaravinos, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00499 · Cited by 349
Twist1 Regulates Vimentin through Cul2 Circular RNA to Promote EMT in Hepatocellular Carcinoma
Meng, J., Chen, S., Han, J.-X., Qian, B., Wang, X.-R., Zhong, W.-L., Qin, Y., Zhang, H., Gao, W.-F., Lei, Y.-Y., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3009 · Cited by 342
Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis
Byun, Y., Chen, F., Chang, R., Trivedi, M., Green, K. J., & Cryns, V. L. (2001) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400840 · Cited by 340
Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas
Jolly, M. K., Somarelli, J. A., Sheth, M., Biddle, A., Tripathi, S. C., Armstrong, A. J., Hanash, S. M., Bapat, S. A., Rangarajan, A., & Levine, H. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.09.007 · Cited by 333
Biomarkers of Epithelial-Mesenchymal Transition in Squamous Cell Carcinoma
Scanlon, C. S., Van Tubergen, E. A., Inglehart, R. C., & D’Silva, N. J. (2013) · Journal of Dental Research · doi:10.1177/0022034512467352 · Cited by 331
The Role of Vimentin Intermediate Filaments in the Progression of Lung Cancer
Kidd, M. E., Shumaker, D. K., & Ridge, K. M. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0314tr · Cited by 330
Histone deacetylase 6 in cancer
Li, T., Zhang, C., Hassan, S., Liu, X., Song, F., Chen, K., Zhang, W., & Yang, J. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0654-9 · Cited by 326
Huang, J.-F., Guo, Y.-J., Zhao, C.-X., Yuan, S.-X., Wang, Y., Tang, G.-N., Zhou, W.-P., & Sun, S.-H. (2013) · Hepatology · doi:10.1002/hep.26195 · Cited by 323
The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer
Thapa, R., & Wilson, G. D. (2016) · Stem Cells International · doi:10.1155/2016/2087204 · Cited by 312
Pearce, D. J., Taussig, D., Simpson, C., Allen, K., Rohatiner, A. Z., Lister, T. A., & Bonnet, D. (2005) · STEM CELLS · doi:10.1634/stemcells.2004-0292 · Cited by 309
Transactivation of Vimentin by Beta-Catenin in Human Breast Cancer Cells
Gilles, C., Polette, M., Mestdagt, M., Nawrocki-Raby, B., Ruggeri, P., Birembaut, P., & Foidart, J.-M. (2003) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-00009577-200303001-00219 · Cited by 301
14-3-3 proteins; bringing new definitions to scaffolding
Tzivion, G., Shen, Y. H., & Zhu, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204777 · Cited by 300
Fang, X., Zheng, P., Tang, J., & Liu, Y. (2010) · Cellular & Molecular Immunology · doi:10.1038/cmi.2009.119 · Cited by 274
Rout-Pitt, N., Farrow, N., Parsons, D., & Donnelley, M. (2018) · Respiratory Research · doi:10.1186/s12931-018-0834-8 · Cited by 274
Vimentin on the move: new developments in cell migration
Battaglia, R. A., Delic, S., Herrmann, H., & Snider, N. T. (2018) · F1000Research · doi:10.12688/f1000research.15967.1 · Cited by 274
Emerging role of tumor cell plasticity in modifying therapeutic response
Qin, S., Jiang, J., Lu, Y., Nice, E. C., Huang, C., Zhang, J., & He, W. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00313-5 · Cited by 268
PKCε‐mediated phosphorylation of vimentin controls integrin recycling and motility
Ivaska, J., Vuoriluoto, K., Huovinen, T., Izawa, I., Inagaki, M., & Parker, P. J. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600847 · Cited by 266
Vimentin Diversity in Health and Disease
Danielsson, F., Peterson, M. K., Caldeira Araújo, H., Lautenschläger, F., & Gad, A. K. B. (2018) · Cells · doi:10.3390/cells7100147 · Cited by 265
Vimentin protects cells against nuclear rupture and DNA damage during migration
Patteson, A. E., Vahabikashi, A., Pogoda, K., Adam, S. A., Mandal, K., Kittisopikul, M., Sivagurunathan, S., Goldman, A., Goldman, R. D., & Janmey, P. A. (2019) · Journal of Cell Biology · doi:10.1083/jcb.201902046 · Cited by 261
Saji, S., Kawakami, M., Hayashi, S.-I., Yoshida, N., Hirose, M., Horiguchi, S.-I., Itoh, A., Funata, N., Schreiber, S. L., Yoshida, M., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208646 · Cited by 258
Vimentin Intermediate Filaments as Potential Target for Cancer Treatment
Strouhalova, K., Přechová, M., Gandalovičová, A., Brábek, J., Gregor, M., & Rosel, D. (2020) · Cancers · doi:10.3390/cancers12010184 · Cited by 255
Vimentin is a novel AKT1 target mediating motility and invasion
Zhu, Q.-S., Rosenblatt, K., Huang, K.-L., Lahat, G., Brobey, R., Bolshakov, S., Nguyen, T., Ding, Z., Belousov, R., Bill, K., et al. (2011) · Oncogene · doi:10.1038/onc.2010.421 · Cited by 246
Self-citationStemness-related markers in cancer
Zhang, X., Zhao, W., & Li, Y. (2017) · Cancer Translational Medicine · doi:10.4103/ctm.ctm_69_16 · Cited by 245
Liu, L.-K., Jiang, X.-Y., Zhou, X.-X., Wang, D.-M., Song, X.-L., & Jiang, H.-B. (2010) · Modern Pathology · doi:10.1038/modpathol.2009.160 · Cited by 241
Gan, Z., Ding, L., Burckhardt, C. J., Lowery, J., Zaritsky, A., Sitterley, K., Mota, A., Costigliola, N., Starker, C. G., Voytas, D. F., et al. (2016) · Cell Systems · doi:10.1016/j.cels.2016.08.007 · Cited by 241
Phenotypic plasticity and epithelial‐mesenchymal transitions in cancer and normal stem cells?
Scheel, C., & Weinberg, R. A. (2011) · International Journal of Cancer · doi:10.1002/ijc.26311 · Cited by 233
Epigenetic regulation of epithelial-mesenchymal transition: focusing on hypoxia and TGF-β signaling
Lin, Y.-T., & Wu, K.-J. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00632-3 · Cited by 229
Plasticity of cancer cell invasion: Patterns and mechanisms
Wu, J.-S., Jiang, J., Chen, B.-J., Wang, K., Tang, Y.-L., & Liang, X.-H. (2021) · Translational Oncology · doi:10.1016/j.tranon.2020.100899 · Cited by 228
Olmeda, D., Moreno-Bueno, G., Flores, J. M., Fabra, A., Portillo, F., & Cano, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2318 · Cited by 226
Jordan, N. V., Johnson, G. L., & Abell, A. N. (2011) · Cell Cycle · doi:10.4161/cc.10.17.17188 · Cited by 220
Clinical significance of the integrin α6β4 in human malignancies
Stewart, R. L., & O'Connor, K. L. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.82 · Cited by 218
Transactivation of vimentin by beta-catenin in human breast cancer cells.
Gilles, C., Polette, M., Mestdagt, M., et al. (2003) · PubMed · Cited by 210
Cheng, C.-W., Wang, H.-W., Chang, C.-W., Chu, H.-W., Chen, C.-Y., Yu, J.-C., Chao, J.-I., Liu, H.-F., Ding, S.-L., & Shen, C.-Y. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2034-4 · Cited by 208
The hypoxic microenvironment: A determinant of cancer stem cell evolution
Carnero, A., & Lleonart, M. (2016) · BioEssays · doi:10.1002/bies.201670911 · Cited by 199
A Direct Interaction between Actin and Vimentin Filaments Mediated by the Tail Domain of Vimentin
Esue, O., Carson, A. A., Tseng, Y., & Wirtz, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605452200 · Cited by 192
Vimentin as a Multifaceted Player and Potential Therapeutic Target in Viral Infections
Ramos, I., Stamatakis, K., Oeste, C. L., & Pérez-Sala, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134675 · Cited by 187
Vimentin: Central hub in EMT induction?
Ivaska, J. (2011) · Small GTPases · doi:10.4161/sgtp.2.1.15114 · Cited by 183
Regulation of vimentin by SIP1 in human epithelial breast tumor cells
Bindels, S., Mestdagt, M., Vandewalle, C., Jacobs, N., Volders, L., Noël, A., Roy, F. V., Berx, G., Foidart, J.-M., & Gilles, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209511 · Cited by 182
Shan, S. W., Fang, L., Shatseva, T., Rutnam, Z. J., Yang, X., Lu, W.-Y., Xuan, J. W., Deng, Z., & Yang, B. B. (2013) · Journal of Cell Science · doi:10.1242/jcs.122895 · Cited by 176
Cancer Stem Cell Plasticity – A Deadly Deal
Thankamony, A. P., Saxena, K., Murali, R., Jolly, M. K., & Nair, R. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00079 · Cited by 171
The roles of ZEB1 in tumorigenic progression and epigenetic modifications
Zhang, Y., Xu, L., Li, A., & Han, X. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.112 · Cited by 170
ZEB1: A Critical Regulator of Cell Plasticity, DNA Damage Response, and Therapy Resistance
Drápela, S., Bouchal, J., Jolly, M. K., Culig, Z., & Souček, K. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00036 · Cited by 165
Genome‐wide cooperation of EMT transcription factor ZEB 1 with YAP and AP ‐1 in breast cancer
Feldker, N., Ferrazzi, F., Schuhwerk, H., Widholz, S. A., Guenther, K., Frisch, I., Jakob, K., Kleemann, J., Riegel, D., Bönisch, U., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019103209 · Cited by 165
Tzivion, G., Luo, Z., & Avruch, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001207200 · Cited by 161
Crosstalk of Oncogenic Signaling Pathways during Epithelial–Mesenchymal Transition
Lindsey, S., & Langhans, S. A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00358 · Cited by 159
Wu, S. K., Du, Y., Beckford, J., & Alachkar, H. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1539-y · Cited by 156
Vimentin–ERK Signaling Uncouples Slug Gene Regulatory Function
Virtakoivu, R., Mai, A., Mattila, E., Franceschi, N. D., Imanishi, S. Y., Corthals, G. L., Kaukonen, R., Saari, M. A., Cheng, F., Torvaldson, E., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2842 · Cited by 152
Dynamic regulation of CD24 and the invasive, CD44posCD24negphenotype in breast cancer cell lines
Meyer, M. J., Fleming, J. M., Ali, M. A., Pesesky, M. W., Ginsburg, E., & Vonderhaar, B. K. (2009) · Breast Cancer Research · doi:10.1186/bcr2449 · Cited by 152
Wang, Y., Liu, J., Ying, X., Lin, P. C., & Zhou, B. P. (2016) · Scientific Reports · doi:10.1038/srep24606 · Cited by 148
Cancer Cells Invade Confined Microchannels via a Self-Directed Mesenchymal-to-Amoeboid Transition
Holle, A. W., Devi, N. G. K., Clar, K. L., Fan, A., Saif, M. T. A., Kemkemer, R., & Spatz, J. P. (2019) · Nano Letters · doi:10.1021/acs.nanolett.8b04720 · Cited by 147
Vimentin filaments interact with the actin cortex in mitosis allowing normal cell division
Duarte, S., Viedma-Poyatos, Á., Navarro-Carrasco, E., Martínez, A. E., Pajares, M. A., & Pérez‐Sala, D. (2019) · Nature Communications · doi:10.1038/s41467-019-12029-4 · Cited by 134
Vimentin is sufficient and required for wound repair and remodeling in alveolar epithelial cells
Rogel, M. R., Soni, P. N., Troken, J. R., Sitikov, A. S., Bittar, H. E. T., & Ridge, K. M. (2011) · The FASEB Journal · doi:10.1096/fj.10-170795 · Cited by 131
Wang, T., Lin, Y.-S., Chen, Y., Yeh, C., Huang, Y., Hsieh, T.-H. J., Shieh, T., Hsueh, C., & Chen, T. (2015) · Oncotarget · doi:10.18632/oncotarget.4344 · Cited by 128
The in vitro DNA-binding properties of purified nuclear lamin proteins and vimentin.
Shoeman, R. L., & Traub, P. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38810-6 · Cited by 127
Smith, B., Burton, L. J., Henderson, V., Randle, D. D., Morton, D. J., Smith, B. A., Taliaferro-Smith, L. D., Nagappan, P., Yates, C. C., Zayzafoon, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104987 · Cited by 127
Cockrell, L. M., Du, Y., Acker, T. M., & Fu, H. (2009) · Wiley eBooks · doi:10.1002/9780470048672.wecb696 · Cited by 122
Oncogenes induce a vimentin filament collapse mediated by HDAC6 that is linked to cell stiffness
Rathje, L.-S. Z., Nordgren, N., Pettersson, T., Rönnlund, D., Widengren, J., Aspenström, P., & Gad, A. K. B. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300238111 · Cited by 121
Filamin A is required for vimentin-mediated cell adhesion and spreading
Kim, H., Nakamura, F., Lee, W., Shifrin, Y., Arora, P. D., & McCulloch, C. A. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00323.2009 · Cited by 116
Major Molecular Signaling Pathways in Oral Cancer Associated With Therapeutic Resistance
Usman, S., Jamal, A., Teh, M., & Waseem, A. (2021) · Frontiers in Oral Health · doi:10.3389/froh.2020.603160 · Cited by 115
Self-citationYeo, C. D., Kang, N., Choi, S. Y., Kim, B. N., Park, C. K., Kim, J. W., Kim, Y. K., & Kim, S. J. (2017) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.302 · Cited by 114
Li, X., Liu, L., Li, D., He, Y., Guo, L., Sun, L., Liu, L., Xu, H., & Zhang, X. (2017) · Scientific Reports · doi:10.1038/srep40464 · Cited by 105
Lilienbaum, A., & Paulin, D. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53979-x · Cited by 99
Microbes-induced EMT at the crossroad of inflammation and cancer
Hofman, P. M., & Vouret‐Craviari, V. (2012) · Gut Microbes · doi:10.4161/gmic.20288 · Cited by 99
Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells
Taddei, M. L., Giannoni, E., Morandi, A., Ippolito, L., Ramazzotti, M., Callari, M., Gandellini, P., & Chiarugi, P. (2014) · Cell Communication and Signaling · doi:10.1186/1478-811x-12-24 · Cited by 96
Masugi, Y., Yamazaki, K., Emoto, K., Effendi, K., Tsujikawa, H., Kitago, M., Itano, O., Kitagawa, Y., & Sakamoto, M. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2014.166 · Cited by 95
Freier, K., Knoepfle, K., Flechtenmacher, C., Pungs, S., Devens, F., Toedt, G., Hofele, C., Joos, S., Lichter, P., & Radlwimmer, B. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20714 · Cited by 95
Wu, Y., Zhang, X., Salmon, M., Lin, X., & Zehner, Z. E. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.11.017 · Cited by 93
Talkenberger, K., Cavalcanti‐Adam, E. A., Voß-Böhme, A., & Deutsch, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-09300-3 · Cited by 91
Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity
Zhang, R., Tu, J., & Liu, S. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.008 · Cited by 91
MicroRNA-17-5p regulates EMT by targeting vimentin in colorectal cancer
Kim, T. W., Lee, Y. S., Yun, N. H., Shin, C. H., Hong, H. K., Kim, H. H., & Cho, Y. B. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0940-5 · Cited by 90
Mechanical and Non‐Mechanical Functions of Filamentous and Non‐Filamentous Vimentin
Patteson, A. E., Vahabikashi, A., Goldman, R. D., & Janmey, P. A. (2020) · BioEssays · doi:10.1002/bies.202000078 · Cited by 86
Kwak, H., Kang, H., Dave, J. M., Mendoza, E. A., Su, S., Maxwell, S. A., & Bayless, K. J. (2012) · Angiogenesis · doi:10.1007/s10456-012-9262-4 · Cited by 84
Wu, A., Luo, W., Zhang, Q., Yang, Z., Zhang, G., Li, S., & Yao, K. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.046 · Cited by 83
AP-1/jun binding sites mediate serum inducibility of the human vimentin promoter
Rittling, S. R., Coutinho, L., Amram, T., & Kolbe, M. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.4.1619 · Cited by 83
Hepatitis C Virus Induces Epithelial-Mesenchymal Transition in Primary Human Hepatocytes
Bose, S. K., Meyer, K., Bisceglie, A. M. D., Ray, R. B., & RAY, R. K. (2012) · Journal of Virology · doi:10.1128/jvi.02016-12 · Cited by 81
Velez‐delValle, C., Marsch‐Moreno, M., Castro‐Muñozledo, F., Galván-Mendoza, I. J., & Kuri‐Harcuch, W. (2016) · Scientific Reports · doi:10.1038/srep24389 · Cited by 75
Yang, Y., Zhang, J., Chen, X., Xu, X., Cao, G., Li, H., & Wu, T. (2018) · Gene Therapy · doi:10.1038/s41434-018-0026-7 · Cited by 75
Vimentin phosphorylation and assembly are regulated by the small GTPase Rab7a
Cogli, L., Progida, C., Bramato, R., & Bucci, C. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.02.024 · Cited by 71
Vimentin protects differentiating stem cells from stress
Pattabiraman, S., Azad, G. K., Amen, T., Brielle, S., Park, J. E., Sze, S. K., Meshorer, E., & Kaganovich, D. (2020) · Scientific Reports · doi:10.1038/s41598-020-76076-4 · Cited by 71
Bayo, P., Jou, A., Stenzinger, A., Shao, C., Gross, M., Jensen, A., Grabe, N., Mende, C. H., Rados, P. V., Debus, J., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.05.006 · Cited by 70
Zhu, Y., Zhang, Y., Sui, Z., Zhang, Y., Liu, M., & Tang, H. (2016) · Oncotarget · doi:10.18632/oncotarget.10706 · Cited by 70
Q&A: Cellular near death experiences—what is anastasis?
Sun, G., & Montell, D. J. (2017) · BMC Biology · doi:10.1186/s12915-017-0441-z · Cited by 69
Vimentin Regulates Scribble Activity by Protecting It from Proteasomal Degradation
Phua, D. C. Y., Humbert, P. O., & Hunziker, W. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-02-0199 · Cited by 68
Epigenetic Mechanisms Influencing Epithelial to Mesenchymal Transition in Bladder Cancer
Monteiro‐Reis, S., Lobo, J., Henrique, R., & Jerónimo, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020297 · Cited by 67
Role of vimentin in modulating immune cell apoptosis and inflammatory responses in sepsis
Su, L., Pan, P., Yan, P., Long, Y., Zhou, X. Q., Wang, X., Zhou, R., Wen, B., Xie, L., & Liu, D. (2019) · Scientific Reports · doi:10.1038/s41598-019-42287-7 · Cited by 67
Arylquins target vimentin to trigger Par-4 secretion for tumor cell apoptosis
Burikhanov, R., Sviripa, V. M., Hebbar, N., Zhang, W., Layton, W. J., Hamza, A., Zhan, C., Watt, D. S., Liu, C., & Rangnekar, V. M. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1631 · Cited by 66
Zhu, S., He, C., Deng, S.-J., Li, X., Cui, S.-P., Zeng, Z., Liu, M., Zhao, S., Chen, J., Jin, Y., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0877 · Cited by 62
Diversity and functional evolution of the plasminogen activator system
Jaiswal, R. K., Varshney, A., & Yadava, P. K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.029 · Cited by 62
Hiramoto, H., Muramatsu, T., Ichikawa, D., Tanimoto, K., Yasukawa, S., Otsuji, E., & Inazawa, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-04191-w · Cited by 60
Breast Carcinoma: From Initial Tumor Cell Detachment to Settlement at Secondary Sites
Melzer, C., von der Ohe, J., & Hass, R. (2017) · BioMed Research International · doi:10.1155/2017/8534371 · Cited by 58
Role of MicroRNA-30c in cancer progression
Han, W., Cui, H., Liang, J., & Su, X. (2020) · Journal of Cancer · doi:10.7150/jca.38449 · Cited by 56
Lavenus, S. B., Tudor, S., Ullo, M. F., Vosatka, K. W., & Logue, J. S. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011537 · Cited by 56
Tolstonog, G. V., Mothes, E., Shoeman, R. L., & Traub, P. (2001) · DNA and Cell Biology · doi:10.1089/104454901317094954 · Cited by 55
Dmello, C., Sawant, S., Alam, H., Gangadaran, P., Mogre, S., Tiwari, R., D'Souza, Z. C., Narkar, M., Thorat, R. A., Patil, K., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172559 · Cited by 55
Deng, Z., Du, W. W., Fang, L., Shan, S. W., Qian, J., Lin, J., Qian, W., Ma, J., Rutnam, Z. J., & Yang, B. B. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.418830 · Cited by 54
Hass, R., von der Ohe, J., & Ungefroren, H. (2020) · Cancers · doi:10.3390/cancers12123674 · Cited by 54
Downregulation of vimentin expression increased drug resistance in ovarian cancer cells
Huo, Y., Zheng, Z., Chen, Y., Wang, Q., Zhang, Z., & Deng, H. (2016) · Oncotarget · doi:10.18632/oncotarget.9970 · Cited by 50
Chakraborty, S., Kumar, A., Faheem, M. M., Katoch, A., Kumar, A., Jamwal, V. L., Nayak, D., Golani, A., Rasool, R. U., Ahmad, S. M., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1690-2 · Cited by 49
Hu, H., Xu, W., Zhang, W., Yan, X., Li, Y., Li, B., & He, Q. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00275-8 · Cited by 48
Impact of Expression of Vimentin and Axl in Breast Cancer
Tanaka, K., Tokunaga, E., Inoue, Y., Yamashita, N., Saeki, H., Okano, S., Kitao, H., Oki, E., Oda, Y., & Maehara, Y. (2016) · Clinical Breast Cancer · doi:10.1016/j.clbc.2016.06.015 · Cited by 46
Vimentin as a target for the treatment of COVID-19
Li, Z., Paulin, D., Lacolley, P. J., Coletti, D., & Agbulut, O. (2020) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2020-000623 · Cited by 39
Dong, Y., Zheng, Y., Wang, C., Ding, X., Du, Y., Liu, L., Zhang, W., Zhang, W., Zhong, Y., Wu, Y., et al. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0619-7 · Cited by 35
Pasquereau-Kotula, E., Faigle, W., Berthault, N., Dingli, F., Loew, D., Sun, J., Dutreix, M., & Quanz, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080313 · Cited by 34
Francart, M., Vanwynsberghe, A. M., Lambert, J., Bourcy, M., Genna, A., Ancel, J., Pérez‐Boza, J., Noël, A., Birembaut, P. L., Struman, I., et al. (2020) · Oncogene · doi:10.1038/s41388-020-1244-1 · Cited by 33
Lin, J., Lü, J., Wang, C., & Xue, X. (2017) · Cancer Cell International · doi:10.1186/s12935-017-0450-6 · Cited by 32
Kim, J., Jang, J., Yang, C., Kim, E., Jung, H., & Kim, C. (2016) · FEBS Letters · doi:10.1002/1873-3468.12430 · Cited by 26
Cancer‐associated thrombosis: The search for the holy grail continues
Ünlü, B., & Versteeg, H. H. (2018) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12143 · Cited by 26
Vimentin binds to G-quadruplex repeats found at telomeres and gene promoters
Ceschi, S., Berselli, M., Cozzaglio, M., Giantin, M., Toppo, S., Spolaore, B., & Sissi, C. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab1274 · Cited by 26
Poly(ADP-ribose) polymerase-1 regulates vimentin expression in lung cancer cells
Chu, S., Xu, H., Ferro, T. J., & Rivera, P. X. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00197.2007 · Cited by 25
Yu, C., WANG, M., Chen, M., Huang, Y., & Jiang, J. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4031 · Cited by 21
Circulating tumor cells and coagulation—Minireview
Bystrický, B., Reuben, J. M., & Mego, M. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.04.003 · Cited by 21
Chang, H., Lee, C.-H., Li, Y.-S., Huang, J.-T., Lan, S., Wang, Y.-F., Lai, W., Wang, Y., Lin, Y.-J., Liu, H., et al. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00693-4 · Cited by 19
Lin, S.-L., Lin, Y.-H., Chi, H., Lin, T.-K., Chen, W.-J., Yeh, C., & Lin, K. (2020) · Cells · doi:10.3390/cells9061504 · Cited by 17
H2AX and EMT: deciphering beyond DNA repair
Weyemi, U., Redon, C. E., & Bonner, W. M. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1160659 · Cited by 16
Emad, A., Ray, T., Jensen, T., Parat, M., Natrajan, R., Sinha, S. K., & Ray, P. S. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/219410 · Cited by 4
Şahin, H., Güngören, A., Sezgin, B., Ün, B., Şahin, E. A., Dolapçıoğlu, K., & Bayık, R. N. (2020) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2019.1671816 · Cited by 3
Cited by
Allgayer, H., Mahapatra, S., Mishra, B., Swain, B., Saha, S., Khanra, S., Kumari, K., Panda, V. K., Malhotra, D., Patil, N. S., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02338-2 · Cited by 127
Cremer, T., Voortman, L. M., Bos, E., Jongsma, M. L., ter Haar, L. R., Akkermans, J. J., Talavera Ormeño, C. M., Wijdeven, R. H., de Vries, J., Kim, R. Q., et al. (2023) · The EMBO Journal · doi:10.15252/embj.2022111252 · Cited by 35
Metadata
- Authors
- Usman, S., Waseem, N. H., Nguyen, T. K. N., Mohsin, S., Jamal, A., Teh, M.-T., & Waseem, A.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2021-10-05
- Volume
- 13
- Issue
- 19
- Pages
- 4985
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W3203638313
- Cited by
- 430
- References
- 147
- FWCI
- 19.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.